Ingredient news
Melissa Phospholipids Study Reports Better Sleep at 400 mg Dose
By Nutranexa News |
A Food & Nutrition Research study found larger sleep-quality and mood improvements after three weeks of higher-dose Melissa phospholipids in adults with emotional distress.
Study Design
The open-label dose-comparison study enrolled 32 adults with poor sleep quality and or clinically significant emotional distress.
Participants received Melissa phospholipids at either 200 mg/day or 400 mg/day for three weeks, with sleep quality tracked using the Pittsburgh Sleep Quality Index.
Main Results
The abstract reported significant improvements in sleep quality over time, with earlier and larger effects at the 400 mg dose.
At 400 mg/day, the study also reported reductions in depression, anxiety, and stress scores, plus improved quality-of-life measures, with no reported adverse effects or significant safety-parameter changes.
Buyer Takeaway
The paper is relevant for phospholipid-delivery suppliers because it supports the commercial conversation around carrier systems, not only the underlying botanical.
The authors also note that placebo-controlled follow-up work is still needed, so this remains an early evidence-building story rather than a finished category conclusion.